These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32982041)

  • 1. 110
    Wechsler ME; Ramirez JEV; Peppas NA
    Ind Eng Chem Res; 2019; 58(33):15079-15087. PubMed ID: 32982041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
    Siafaka PI; Mutlu G; Okur NÜ
    Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer's Disease Management.
    Dighe S; Jog S; Momin M; Sawarkar S; Omri A
    Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics.
    Hettiarachchi SD; Zhou Y; Seven E; Lakshmana MK; Kaushik AK; Chand HS; Leblanc RM
    J Control Release; 2019 Nov; 314():125-140. PubMed ID: 31647979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Treatment of Alzheimer's Disease Using Nanoparticle-Based Drug Delivery Systems.
    Poudel P; Park S
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome based drug delivery as a potential treatment option for Alzheimer's disease.
    Hernandez C; Shukla S
    Neural Regen Res; 2022 Jun; 17(6):1190-1198. PubMed ID: 34782553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanoparticles: A promising strategy for treatment of Alzheimer's disease.
    Elmahboub YSM; Elkordy AA
    J Taibah Univ Med Sci; 2024 Jun; 19(3):549-565. PubMed ID: 38736898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
    Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
    J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic nanoplatforms and delivery strategies for neurological disorders.
    Kang YJ; Cutler EG; Cho H
    Nano Converg; 2018 Nov; 5(1):35. PubMed ID: 30499047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease.
    Unnisa A; Greig NH; Kamal MA
    Curr Med Chem; 2023; 30(3):255-270. PubMed ID: 35345990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer's disease.
    Faustino C; Rijo P; Reis CP
    Pharmacol Res; 2017 Jun; 120():68-87. PubMed ID: 28351757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives.
    Zakharova L; Gaynanova G; Vasilieva E; Vasileva L; Pavlov R; Kashapov R; Petrov K; Sinyashin O
    Curr Med Chem; 2023; 30(33):3743-3774. PubMed ID: 36380443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
    Roney C; Kulkarni P; Arora V; Antich P; Bonte F; Wu A; Mallikarjuana NN; Manohar S; Liang HF; Kulkarni AR; Sung HW; Sairam M; Aminabhavi TM
    J Control Release; 2005 Nov; 108(2-3):193-214. PubMed ID: 16246446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease.
    Kaur I; Kumar A; Behl T; Setia D
    Curr Drug Targets; 2021; 22(12):1404-1423. PubMed ID: 33397264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
    Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
    Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nanoparticles for brain delivery of drugs or contrast agents. Application to Alzheimer's disease].
    Andrieux K; Couvreur P
    Biol Aujourdhui; 2012; 206(3):185-90. PubMed ID: 23171841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition.
    Gorain B; Rajeswary DC; Pandey M; Kesharwani P; Kumbhar SA; Choudhury H
    Curr Pharm Des; 2020; 26(19):2233-2246. PubMed ID: 32167424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.